Literature DB >> 7077540

A technique to study hepatic and intestinal drug metabolism separately in the dog.

D J Effeney, S M Pond, M W Lo, B M Silber, S Riegelman.   

Abstract

A model to study hepatic and intestinal drug metabolism in the dog has been evaluated. The model is made by performing a portacaval transposition, cholecystectomy and inserting a Thomas cannula into the duodenum. The result is a healthy animal in which drugs can be infused either in a normal i.v. (forelimb) fashion, directly into the liver (hindlimb) or given orally. Blood can be sampled from a peripheral vein, peripheral artery or hepatic vein. Bile and urine can be collected continuously. Pharmacokinetics can be studied in awake, unmedicated animals. The model can be used to assess oral, i.v. or hepatic infusion of drugs and their hepatic, intestinal or pulmonary metabolism.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7077540

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  5 in total

1.  Pharmacokinetic screening of o-naphthoquinone 5-lipoxygenase inhibitors.

Authors:  A Rakhit; S K Kuwahara; D R Jones; V F Soliman; A N Kotake; T D Oglesby; J W Wasley; S L Tripp; F L Douglas
Journal:  Pharm Res       Date:  1990-10       Impact factor: 4.200

2.  Non-linear hepatic first-pass metabolism of salicylamide in dogs after portacaval transposition.

Authors:  S M Pond; V Mahachai; D J Effeney; T N Tozer
Journal:  J Pharmacokinet Biopharm       Date:  1988-04

3.  Nonlinear formation of propranolol metabolites in dogs after portacaval transpositions.

Authors:  M W Lo; S M Pond; D J Effeney; B M Silber; S Riegelman; T N Tozer
Journal:  J Pharmacokinet Biopharm       Date:  1984-08

4.  Induction of quinidine metabolism and plasma protein binding by phenobarbital in dogs.

Authors:  A Rakhit; N H Holford; D J Effeney; S Riegelman
Journal:  J Pharmacokinet Biopharm       Date:  1984-10

5.  Evaluation of intestinal absorption into the portal system in enterohepatic circulation by measuring the difference in portal-venous blood concentrations of diclofenac.

Authors:  K Tabata; K Yamaoka; T Fukuyama; T Nakagawa
Journal:  Pharm Res       Date:  1995-06       Impact factor: 4.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.